Page last updated: 2024-10-31

nadifloxacin and Bacterial Skin Diseases

nadifloxacin has been researched along with Bacterial Skin Diseases in 3 studies

nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Nadifloxacin was active against all aerobic and anaerobic isolates."1.32Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections. ( Haustein, UF; Hittel, N; Nenoff, P, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanayama, S1
Ikeda, F1
Okamoto, K1
Nakajima, A1
Matsumoto, T1
Ishii, R1
Amano, A1
Matsuzaki, K1
Matsumoto, S1
Nenoff, P1
Haustein, UF1
Hittel, N1
Komagata, Y1
Komiyama, K1
Nomura, S1

Other Studies

3 other studies available for nadifloxacin and Bacterial Skin Diseases

ArticleYear
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:10

    Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female;

2016
Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Chemotherapy, 2004, Volume: 50, Issue:4

    Topics: Administration, Topical; Bacteria, Aerobic; Bacteria, Anaerobic; DNA Damage; Fluoroquinolones; Gram-

2004
[Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:2

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Dose-Re

1998